IXEKIZUMAB: A MONOCLONAL ANTIBODY WELL WORTH FOR PSORIASIS

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2017, Vol 3, Issue 1

Abstract

Psoriasis is a very long lasting disease affecting millions of people worldwide. In the patients affected by psoriasis, the skin cells multiply faster than normal and raised and red plaques appeared over the skin. Psoriasis also has association with psoriatic arthritis, increased risk of depression, diabetes and cardiovascular disease. It is an autoimmune disease and complete cure cannot be achieved when all the current treatment options can relieve the symptoms only for a short time. After a very long searching of more sustainably effective drugs for psoriasis, the FDA recently approved the new drug ixekizumab. Ixekizumab is a humanized IgG4 variant IL- 17A neutralizing monoclonal antibody. It has high affinity for human IL- 17A and effectively inhibits the binding of IL- 17A to IL- 17A receptor. As the pathogenesis of autoimmune psoriasis is contributed by IL-17A producing pathogenic T-cells, ixekizumab can completely or almost completely clear the disease in moderate to severe psoriasis. The major drawback is that ixekizumab is an immunosuppressive agent causing increased risk of infection. Ixekizumab brings the hope to psoriatic patients but further immense research needs to be performed in the treatment of psoriasis.

Authors and Affiliations

Dr. Dick B. S. Brashier

Keywords

Related Articles

PHYTOCHEMICAL ANALYSIS AND ANTIMICROBIAL ACTIVITY OF DIOSCOREA BULBIFERA (L.) KUNTH

Dioscorea bulbifera, a climber of family Dioscoreaceae. Widely distributed around the world in tropical and subtropical regions, a plant where collected by forest near lakhani village. The bulb of this clamber called air...

FORMULATING FAST DISINTEGRATING ZINC TABLET USING SINGLE STRUERS LABOPRESS-1

The purpose of our research work was to formulate tablets of zinc as a nutritious element by direct compression method employing different disintegrants and ascorbic acid as an antioxidant at different proportions in add...

VAMANA SHATAKAM: PROCEEDINGS

Vasant ritu is meant for shodhan of kapha & kapha-pitta as there is provocation of kapha naturally which is accumulated in Hemant ritu. So it was planned to perform maximum vaman in a single day in Vasant ritu considerin...

REVIEW ON GASTRORETENTIVE MUCOADHESIVE MICROSPHERE

The current article focuses on the principles of mucoadhesive drug delivery systems based on adhesion to biological surfaces that are covered by mucus. In recent years scientific and technological advancements have been...

GC-MS ANALYSIS AND ANTIMICROBIAL ACTIVITY OF SUDANESE ALLIUM CEPA L. FIXED OIL

The present study was undertaken to identify and quantify the chemical constituents of seed oils from two cultivated varieties of Allium cepa – red onion and white onion and to evaluate their potential antimicrobial acti...

Download PDF file
  • EP ID EP648171
  • DOI -
  • Views 211
  • Downloads 0

How To Cite

Dr. Dick B. S. Brashier (2017). IXEKIZUMAB: A MONOCLONAL ANTIBODY WELL WORTH FOR PSORIASIS. World Journal of Pharmaceutical and life sciences, 3(1), 151-157. https://europub.co.uk/articles/-A-648171